Relay Therapeutics Inc. Common Stock vs SK Hynix — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B), while SK Hynix trades at $169.03 (market cap $891.31B). The key difference: SK Hynix is far larger — about 233.3× Relay Therapeutics Inc. Common Stock's market cap, and SK Hynix pays a 0.06% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and SK Hynix for 10 Days on average.
| RLAY | SKHY | |
|---|---|---|
Market Cap | $3.82B | $891.31B |
Volume | 4,332,079 | 22,268,296 |
Sector | Health | Technology |
52-Week High | $20.75 | $198.63 |
52-Week Low | $6.03 | $126.79 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $2.93B | $841.45B |
Dividend Yield | — | 0.06% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.
Read more on SKHY →